NCT03139318

Phase I Clinical Trial of GRID Therapy in Pediatric Osteosarcoma of the Extremity

• Status: Terminated
• Phase: N/A
• Study type: Interventional
• Enrollment: 1 (actual)
• Sponsor: University of Arkansas · Academic / Other
• Sex: All
• Age: 5 Years – 21 Years
• Healthy volunteers: Not accepted

Summary

The primary objective of this study is to evaluate the toxicity profile of GRID therapy using dose levels of 10Gy, 15 Gy and 20Gy in pediatric osteosarcoma of the extremity.

Detailed description

Subjects will receive GRID radiotherapy. GRID radiation therapy is considered a standard radiation therapy method however is not typically used in pediatric osteosarcoma patients. This protocol will evaluate whether or not the use of this therapy will provide benefit to this patient population.

Conditions

• Osteosarcoma in Children
• Radiation Toxicity

Interventions

Type	Name	Description
RADIATION	GRID radiotherapy	Patients will be treated with GRID radiotherapy

Timeline

• Start date: 2017-07-25
• Primary completion: 2018-08-29
• Completion: 2018-08-29
• First posted: 2017-05-03
• Last updated: 2022-07-20
• Results posted: 2022-07-12

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated device study